跳至主要内容
临床试验/NCT03054662
NCT03054662已完成不适用

Non Substitutive Strategies to Improve Haemophilia Care in Developing Countries. Experience in Ivory Coast.

Cliniques universitaires Saint-Luc- Université Catholique de Louvain1 个研究点 分布在 1 个国家目标入组 142 人开始时间: 2017年1月16日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
142
试验地点
1
主要终点
Improve haemophilia diagnosis of haemophilia in Ivory Coast

研究概览

简要总结

This study aims to make an inventory of the condition and care of patients with haemophilia and carriers for haemophilia in Ivory Coast and to promote the use non substitutive strategies that are not costly and available in Ivory Coast, to improve the management of haemophilia in this country. The purpose of this project is to evaluate the extent to which the active promotion of these various measures will improve the care of patients with haemophilia and carriers in Ivory Coast.

详细描述

  1. Establish a baseline of the condition of haemophilia in Ivory Coast (number of patients, demographics, reassessment of diagnosis, joint status...).(year 1)
  2. Develop tools to assess the intervention (eg transcultural validation of QoL questionnaires, develop booklets to record bleedings...). (year 1)
  3. Intervention phase that will focus on education of patients and their family, education of caregivers, training of the laboratory to the diagnosis of haemophilia and promotion of non substitutive strategies to improve haemophilia care in Ivory Coast (DDAVP, antifibrinolytics, physiotherapy, dental care,...).
  4. Follow-up phase during 2 years.
  5. Outcome analysis

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
12 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Males with severe and moderate haemophilia A and B in Ivory Coast (any age).
  • •Females over 12 years who are carriers for severe and moderate haemophilia A and B in Ivory Coast.

排除标准

  • •subjects not willing to participate.

研究组 & 干预措施

Patients with Haemophilia

Experimental

Male patients with severe and moderate haemophilia A and B in Ivory Coast

干预措施: Implement haemostatic non substitutive care of haemophilia (Drug)

Patients with Haemophilia

Experimental

Male patients with severe and moderate haemophilia A and B in Ivory Coast

干预措施: Implement non haemostatic care of haemophilia (Other)

Carriers for Haemophilia

Experimental

Carriers for severe and moderate haemophilia A and B in Ivory Coast

干预措施: Education (Other)

Patients with Haemophilia

Experimental

Male patients with severe and moderate haemophilia A and B in Ivory Coast

干预措施: Improve biological diagnosis and follow-up of haemophilia (Diagnostic Test)

Patients with Haemophilia

Experimental

Male patients with severe and moderate haemophilia A and B in Ivory Coast

干预措施: Education (Other)

Carriers for Haemophilia

Experimental

Carriers for severe and moderate haemophilia A and B in Ivory Coast

干预措施: Implement haemostatic non substitutive care of haemophilia (Drug)

Carriers for Haemophilia

Experimental

Carriers for severe and moderate haemophilia A and B in Ivory Coast

干预措施: Improve biological diagnosis and follow-up of haemophilia (Diagnostic Test)

结局指标

主要结局

Improve haemophilia diagnosis of haemophilia in Ivory Coast

时间窗: 3 years

Compare the number of patients with haemophilia between the beginning and the end of the study

Improve knowledge about haemophilia in Ivory Coast

时间窗: 2 years after intervention

Compare the knowledge queestionnaires about haemophilia before and after the intervention phase

Improve haemophilia care in Ivory Coast

时间窗: 2 years after intervention

Compare the pain assessment before and after the intervention phase

次要结局

未报告次要终点

研究者

发起方
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验